Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | -1.49% | +4.76% | +123.73% |
05-21 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
05-21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+123.73% | 41.9M | |
+8.92% | 114B | |
+10.48% | 105B | |
-2.85% | 21.73B | |
-6.45% | 23.83B | |
-10.65% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- Transcript : DURECT Corporation, Q1 2024 Earnings Call, May 13, 2024